A new classification system for NSCLC: what do we expect from imaging?

P. E. Postmus (Amsterdam, Netherlands)

Source: Annual Congress 2009 - The new classification system of nonsmall cell lung cancer: a challenge for imaging

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. E. Postmus (Amsterdam, Netherlands). A new classification system for NSCLC: what do we expect from imaging?. Annual Congress 2009 - The new classification system of nonsmall cell lung cancer: a challenge for imaging

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is the current staging system realistic for SCLC?
Source: Eur Respir J 2003; 22: Suppl. 45, 28s
Year: 2003

A network lung cancer pathway in review: Are we choosing the right diagnostic approach?
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010


Integration of molecular testing in the classification of NSCLC: the French experience
Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science
Year: 2014



Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


A new tool for lung imaging: vibration response imaging (VRI). Experience in a paediatric population
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009



Eminence or evidence based ? – personalised diagnostic-therapeutic sequences in a molecular altered advanced NSCLC patient
Source: International Congress 2017 – GR2 Lung Cancer Grand Round
Year: 2017


What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities
Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules
Year: 2018


Can we expect progress from targeted therapy of SCLC?
Source: Eur Respir Monogr 2015; 68: 234-246
Year: 2015


Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the radiotherapist
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Is CT-based screening for lung cancer finally ready for prime time?
Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer
Year: 2012



From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017


Imaging and staging: impact of new techniques
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006

What features do patients and clinicians ‘want’ in the future Internet-Of-Things (IoT) systems for asthma: a mixed method study
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020


Lung cancer staging: imagine fewer images
Source: Eur Respir J, 52 (2) 1801093; 10.1183/13993003.01093-2018
Year: 2018



Lung cancer staging: imagine fewer images
Source: Eur Respir J, 52 (2) 1801314; 10.1183/13993003.01314-2018
Year: 2018



Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the (pneumo) oncologist
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019